Search
for
Sort by
Research 211–240 of 1000+
- Immune therapies for alopecia areata: evidence and new perspectives
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- A review of Janus kinase inhibitor use in scarring alopecia
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- 691 Topical curcumin promotes induction of the murine hair cycle
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- ALOPECIA AREATA: PADRÕES DE QUEDA DE CABELO, MODALIDADES DE TRATAMENTO E IMPACTO PSICOLÓGICO
- Janus kinase inhibitors for alopecia areata: A narrative review
- Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Topical SCD-153, a 4-methyl itaconate prodrug, for the treatment of alopecia areata
- The immunopathogenesis of Alopecia Areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions